Assessing medication appropriateness in the elderly. A review of available measures

Drugs and Aging

Volumn 16, Issue 6, 2000, Pages 437-450

  Shelton, Penny S ^a,d   Fritsch, Michelle A ^b   Scott, Mollie A ^c  

^a Resources for Seniors   (United States)

^b Alamance Regional Medical Center   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; DRUG THERAPY; DRUG USE; GERIATRICS; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033946362     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200016060-00004     Document Type: Review

References (70)

1. Hall WJ. Update in geriatrics. Ann Intern Med 1997; 127 (7): 557-64
2. Stewart RB. Drug use in the elderly. In: Delafuente JC, Stewart RB, editors. Therapeutics in the elderly. 2nd ed. Cincinnati: Harvey Whitney Books, 1995: 174-89
3. Broderick E. Prescribing patterns for nursing home residents in the US: the reality and the vision. Drugs Aging 1997; 11: 255-60
4. Chrischilles EA, Foley DJ, Wallace RB, et al. Use of medications by persons 65 and over: data from the Established Populations for Epidemiologic Studies of the Elderly. J Gerontol 1992; 47: M137-44
5. Chrischilles EA, Segar ET, Wallace RB. Self-reported adverse drug reactions and related resource use: a study of community-dwelling persons 65 years of age and older. Ann Intern Med 1992; 117: 634-40
6. Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997; 45: 945-8
7. May JR. Adverse drug reactions and interactions. In: Dipiro JT, Talbert RL, Yee GC, et al., editors. Pharmacotherapy: a pathophysiologic approach. 3rd ed. Stamford: Appleton and Lange, 1997: 101-16
8. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescibing cascade. BMJ 1997; 315: 1096-9
9. Graves T, Hanlon JT, Schmader KE, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med 1997; 157: 2205-10
10. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs and attributable mortality. JAMA 1997; 277 (4): 301-6
11. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-5
12. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med 1995; 155: 1949-56
13. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 1995; 274: 29-34
14. Beers MH, Storrie M, Lee G. Potential adverse drug interactions in the emergency room: an issue in the quality of care. Ann Intern Med 1990; 112: 61-4
15. Costa AJ. Potential drug interactions in an ambulatory geriatric population. Fam Practice 1991; 8: 234-6
16. Gosney M, Tallis R. Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet 1984; II: 564-7
17. Jankel CA, McMillan JA, Martin BC. Effect of drug interactions on outcomes of patients receiving warfarin or theophylline. Am J Hosp Pharm 1994; 51: 661-6
18. Hamilton RA, Gordon T. Incidence and cost of hospital admissions secondary to drug interactions involving theophylline. Ann Pharmacother 1992; 26: 1507-11
19. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531-6
20. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330: 592-6
21. Perez-Stable EJ, Miranda J, Munoz RF, et al. Depression in medical outpatients: underrecognition and misdiagnosis. Arch Intern Med 1990; 150: 1083-8
22. Gurwitz JH, Monette J, Rochon PA, et al. Atrial fibrillation and stroke prevention with warfarin the long-term care setting. Arch Intern Med 1997; 157: 978-84
23. Stuck AE, Tamai IY. Medication management in the home. Clin Geriatr Med 1991; 7 (4): 733-48
24. Monane M, Monane S, Semla T. Optimal medication use in elders: key to successful aging. West J Med 1997; 167: 233-7
25. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med 1989; 321: 303-9
26. Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684-9
27. Spore DL, Mor V, Larrat P, et al. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Pub Health 1997; 87: 404-9
28. Aparasu RR, Fliginger SE. Inappropriate medication prescribing for the elderly by office-based physicians. Ann Pharmacother 1997; 31: 823-9
29. Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Questionable prescribing for elderly patients in Quebec. Can Med Assoc J 1994; 150(11): 1801-9
30. Torrible SJ, Hogan DB. Medication use and rural seniors: who really knows what they are taking? Can Fam Physician 1997; 43: 893-989
31. Der EH, Rubenstein LZ, Choy GS. The benefits of in-home pharmacy evaluation for older persons. J Am Geriatr Soc 1997; 45 (2): 211-4
32. Hunter KA, Florio ER, Langberg RG. Pharmaceutical care for home-dwelling elderly persons: a determination of need and program description. Gerontologist 1996; 36 (4): 543-8
33. Schrader SL, Dressing B, Blue R, et al. The Medication Reduction Project: combatting polypharmacy in South Dakota elders through community-based interventions. S D J Med 1996; 49 (12): 441-8
34. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825-32
35. Shelton PS, Hanlon JT, Landsman PB, et al. Reliability of drug utilization evaluation as an assessment of medication appropriateness. Ann Pharmacother 1997; 31: 533-42
36. Morris JN, Hawes C, Murphy K, et al. Resident assessment instrument training manual and resource guide. Natick (MA): Eliot Press, 1991
37. Hanlon JT, Schmader KE, Samsa GP, et al. Amethod for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045-51
38. Hamdy RC, Moore SW, Whalen K, et al. Reducing polypharmacy in extended care. South Med J 1995; 88 (5): 534-8
39. Owens NJ, Sherburne NJ, Silliman RA, et al. The Senior Care Study: the optimal use of medications in acutely ill older patients. J Am Geriatr Soc 1990; 38: 1082-7
40. Johnson RE, Campbell WH, Azevedo DJ, et al. Studying the impact of patient drug profiles in an HMO. Med Care 1976; 14: 799-807
41. Koepsell TD, Gurtel AL, Diehr PH, et al. The Seattle evaluation of computerized drug profiles: effects on prescribing practice and resource use. Am J Pub Health 1983; 73: 850-5
42. Tamai IY, Rubenstein LZ, Josephson KR, et al. Impact of computerized drug profiles and a consulting pharmacist on outpatient prescribing patterns: a clinical trial. Drug Intell Clin Pharm 1987; 21: 890-5
43. Stuck AE, Beers MH, Steiner A, et al. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994; 154: 2195-200
44. Anderson GM, Beers MH, Kerluke K. Auditing prescription practice using explicit criteria and computerized drug benefit claims data. J Evalu Clin Pract 1997; 3 (4): 283-94
45. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994; 272 (4): 292-6
46. McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 1997; 156 (3): 385-91
47. Oborne CA, Batty GM, Maskrey V, et al. Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 1997; 43: 91-7
48. Knapp DA. Development of criteria for drug utilization review. Clin Pharm Ther 1991; 50 (5): 600-5
49. Davidson HE, Chamberlain TM, Hernandez P, et al. Drug-use evaluation, part II: Drug-use analysis in pharmaceutical care and quality assurance. Consult Pharmacist 1991; 6 (10): 836-43
50. Ben-Joseph R, Segal R, Russell WL, et al. Evaluating the value, accuracy and operational feasibility of DUE criteria. Formulary 1995; 30: 280-3
51. Winslade NE, Bajcare JM, Bombassaro AM, et al. Pharmacist's management of drug-related problems: a tool for teaching and providing pharmaceutical care. Pharmacotherapy 1997; 17 (4): 801-9
52. Robertson KE. Process for preventing or identifying and resolving problems in drug therapy. Am J Health Syst Pharm 1996; 53: 639-50
53. Newton PF, Levinson W, Maslen D. The Geriatric Medication Algorithm: a pilot study. J Gen Intern Med 1994; 9 (3): 164-7
54. Lipton HL, Bird JA, Bero LA, et al. Assessing the appropriateness of physician prescribing for geriatric outpatients: development and testing of an instrument. J Pharm Technol 1993; 9: 107-13
55. Owens NJ, Fretwell MD, Willey C, et al. Distinquishing between the fit and frail elderly, and optimising pharmacotherapy. Drugs Aging 1994; 4 (1): 47-55
56. Morris JN, Hawes C, Fries BE, et al. Designing the national resident assessment instrument for nursing homes. Gerontologist 1990; 30: 293-307
57. Riley K. Putting the MDS 2.0 to work in long-term care. Consult Pharmacist 1996; 11 (7): 669-75
58. Riley K. RAPs and the consultant pharmacist. Consult Pharmacist 1997; 12 (1): 32-4
59. Morris JN, Fries BE, Knight S, et al. Comprehensive clinical assessment in community setting: applicability of the MDS-HC. J Am Geriatr Soc 1997; 45: 1017-24
60. Morris JN, Nonemaker S, Murphy K, et al. A commitment to change: revision of HCFA's RAI. J Am Geriatr Soc 1997; 45: 1011-16
61. Ouslander JG. The resident assessment instrument (RAI): promises and pitfalls. J Am Geriatr Soc 1997; 45: 975-6
62. Losben NL. Putting the MDS 2.0 to work to identify and monitor at-risk elderly. Consult Pharmacist 1997; 12 (5): 520-34
63. Tobias DE, Feinberg JL, Troutman WG. The MDS-Med Guide: a tool for the new millenium. Consult Pharmacist 1999; 14 (8): 831-60
64. Samsa GP, Hanlon JT, Schmader KE, et al. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994; 47: 891-6
65. Schmader KE, Hanlon JT, Weinberger M, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994; 42: 1241-7
66. Schmader KE, Hanlon JT, Landsman PB, et al. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother 1997; 31: 529-33
67. Fitzgerald LS, Hanlon JT, Shelton PS, et al. Reliability of a modified medication appropriateness index in ambulatory older persons. Ann Pharmacother 1997; 31: 543-8
68. Naranjo CA, Busto U, Sellers EM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45
69. Kramer MS, Leventhal JM, Hutchinson TA, et al. An algorithm for the operational assessment of adverse drug reactions. J Am Med Assoc 1979; 242: 623-32
70. Hepler DC, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-43